Anbio Biotechnology
NNNN· Nasdaq
Anbio Biotechnology
- Last sale
- Oct 2, 2026 · -9.73%
- Market cap
- $814.42M
- 143.89M shares
- Filings
- 43
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $8,646,844 | reported | |
| FY 2024 | 2024-12-31 | $8,185,146 | reported | |
| FY 2023 | 2023-12-31 | $6,711,990 | reported | |
| FY 2022 | 2022-12-31 | $23,544,652 | reported |
Anbio Biotechnology · CIK 1982708 · Engraved from SEC EDGAR
